Craig A. Paterson - 06 Jan 2023 Form 4 Insider Report for Allakos Inc. (ALLK)

Role: Chief Medical Officer
Signature: /s/ H. Baird Radford, III, by power of attorney
Issuer symbol: ALLK
Transactions as of: 06 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 09 Jan 2023, 17:15:14 UTC
Previous filing: 05 Dec 2022
Next filing: 06 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALLK	Common Stock	Award	$0	+102,690	+38%	$0.000000	372,474	06 Jan 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALLK	Stock Option (Right to buy)	Award	$0	+157,428		$0.000000	157,428	06 Jan 2023	Common Stock	157,428	$7.20	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Mr. Paterson was awarded 102,690 restricted stock units ("RSUs") pursuant to the Company's 2018 Equity Incentive Plan on January 6, 2023, of which, 25% will vest on March 1, 2024, and the remainder of the RSUs will vest in 12 equal installments on each three month anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F2	Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
F3	The option was granted on January 6, 2023. The option vests as to one-fourth of the shares on January 6, 2024, and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.